Glen Harbor Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $568K | Buy |
2,078
+293
| +16% | +$80.1K | 0.01% | 658 |
|
|
2019
Q2 | $953K | Sell |
1,785
-610
| -25% | -$326K | 0.02% | 497 |
|
|
2019
Q1 | $1.21M | Sell |
2,395
-5,697
| -70% | -$2.87M | 0.03% | 425 |
|
|
2018
Q4 | $3.99M | Buy |
8,092
+1,542
| +24% | +$760K | 0.1% | 210 |
|
|
2018
Q3 | $5.99M | Buy |
6,550
+5,796
| +769% | +$5.3M | 0.12% | 167 |
|
|
2018
Q2 | $552K | Buy |
754
+513
| +213% | +$376K | 0.01% | 610 |
|
|
2018
Q1 | $384K | Sell |
241
-1,040
| -81% | -$1.66M | 0.01% | 733 |
|
|
2017
Q4 | $1.15M | Buy |
1,281
+219
| +21% | +$196K | 0.03% | 402 |
|
|
2017
Q3 | $382K | Buy |
1,062
+144
| +16% | +$51.8K | 0.01% | 677 |
|
|
2017
Q2 | $269K | Buy |
918
+395
| +76% | +$116K | 0.01% | 786 |
|
|
2017
Q1 | $184K | Buy |
523
+53
| +11% | +$18.6K | ﹤0.01% | 761 |
|
|
2016
Q4 | $87K | Buy |
+470
| New | +$87K | ﹤0.01% | 945 |
|